Literature DB >> 17660340

Thyroid transcription factor-1 may be expressed in ductal adenocarcinoma of the prostate:a potential pitfall.

Tony Kiat-Hon Lim1, Clarence Teo, Danilo M Giron, Yew-Lam Chong, Christopher Cheng, Puay-Hoon Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17660340      PMCID： PMC1994507          DOI： 10.1136/jcp.2007.047829

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  20 in total

1.  Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study.

Authors:  Victor WengLeong Ng; Magdalene Koh; Soo Yong Tan; Puay Hoon Tan
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

2.  Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites.

Authors:  A M Oliveira; H D Tazelaar; J L Myers; L A Erickson; R V Lloyd
Journal:  Am J Surg Pathol       Date:  2001-06       Impact factor: 6.394

3.  Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.

Authors:  Josef Zamecnik; Roman Kodet
Journal:  Virchows Arch       Date:  2001-10-19       Impact factor: 4.064

4.  Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.

Authors:  P A Bejarano; R P Baughman; P W Biddinger; M A Miller; C Fenoglio-Preiser; B al-Kafaji; R Di Lauro; J A Whitsett
Journal:  Mod Pathol       Date:  1996-04       Impact factor: 7.842

5.  Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.

Authors:  S N Agoff; L W Lamps; A T Philip; M B Amin; R A Schmidt; L D True; A L Folpe
Journal:  Mod Pathol       Date:  2000-03       Impact factor: 7.842

6.  Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas.

Authors:  W Cheuk; M Y Kwan; S Suster; J K Chan
Journal:  Arch Pathol Lab Med       Date:  2001-02       Impact factor: 5.534

7.  Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade.

Authors:  V Jerome Marson; J Mazieres; O Groussard; O Garcia; J Berjaud; M Dahan; P Carles; G Daste
Journal:  Histopathology       Date:  2004-08       Impact factor: 5.087

8.  Expression of thyroid transcription factor 1 in primary brain tumours.

Authors:  J Zamecnik; M Chanova; R Kodet
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

9.  Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity.

Authors:  Pablo A Bejarano; Fathema Mousavi
Journal:  Arch Pathol Lab Med       Date:  2003-02       Impact factor: 5.534

10.  Cytoplasmic immunoreactivity for thyroid transcription factor-1 in hepatocellular carcinoma: a comparative immunohistochemical analysis of four commercial antibodies using a tissue array technique.

Authors:  Chin-Chen Pan; Paul Chih-Hsueh Chen; Shyh-Haw Tsay; Hung Chiang
Journal:  Am J Clin Pathol       Date:  2004-03       Impact factor: 2.493
View more
  2 in total

Review 1.  The update of prostatic ductal adenocarcinoma.

Authors:  Tantan Liu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

2.  Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.

Authors:  Andres Matoso; Kamaljeet Singh; Rafik Jacob; Wesley O Greaves; Rosemarie Tavares; Lelia Noble; Murray B Resnick; Ronald A Delellis; Li J Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.